Y-mAbs Therapeutics, Inc. (YMAB) Balance Sheet Annual - Discounting Cash Flows
YMAB
Y-mAbs Therapeutics, Inc.
YMAB (NASDAQ)
Period Ending: 2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
Report Filing: 2025-03-04 2024-02-29 2023-03-30 2022-03-01 2021-03-01 2020-03-12 2019-03-22 2017-12-31 2016-12-31
Total Current Assets 98.51 111.1 130.4 202.3 122.4 212 151.5 91.36 17.26
Cash and Short Term Investments 67.23 78.64 105.8 181.6 114.6 207.1 147.8 90.48 16.88
Cash & Equivalents 67.23 78.64 105.8 181.6 114.6 207.1 147.8 90.48 16.88
Short Term Investments 0 0 0 0 0 0 0 0 0
Receivables 19.69 22.45 12.53 7.71 0 0 0 0 0
Inventory 7.21 5.07 6.7 5.51 0 0 0 0 0
Other Current Assets 4.37 4.96 5.45 7.47 7.73 4.82 3.69 0.872 0.386
Total Assets 119.9 127.9 141.5 212.8 132 216.4 151.9 92.13 17.26
Total Non-Current Assets 21.39 16.76 11.01 10.52 9.68 4.41 0.392 0.772 0
Property, Plant and Equipment 0.859 1.64 2.34 5.69 6.39 4.04 0.205 0 0
Goodwill and Intangible Assets 2.28 2.63 2.99 1.66 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0
Intangible Assets 2.28 2.63 2.99 1.66 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0
Deferred Tax Assets 0 0 0 0 0 0 0 0 0
Other Long Term Assets 18.26 12.49 5.68 3.17 3.29 0.37 0.187 0.772 0
Total Current Liabilities 23.7 20.13 28.28 27.88 19.54 13.59 9.12 7.92 2.98
Accounts Payable 6.66 6.06 14.18 13.55 9.37 8.52 5.87 5.91 2.23
Notes Payable/Short Term Debt 0.63 1.8 0.868 1.78 1.97 0.516 0 0 0
Tax Payables 0 0 0 0 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0
Other Current Liabilities 16.41 12.26 13.24 12.54 8.2 4.55 3.25 2.02 0.748
Total Liabilities 27.9 26.88 32.23 32.68 26.21 17.46 11.4 9.97 5.2
Total Non-Current Liabilities 4.2 6.76 3.95 4.8 6.68 3.88 2.27 2.05 2.23
Total Long Term Debt 0.19 0.517 0.899 1.85 2.01 1.71 0 0 0
Deferred Tax Liabilities Non-Current 0 0 0 0 0 0 0 0 0
Deferred Revenue Non-Current 0 0 0 0 0 0 0 0 0
Capital Lease Obligations 0.82 1.42 1.77 3.63 3.98 2.23 0 0 0
Other Long Term Liabilities 3.19 4.82 1.28 -0.683 0.684 -0.067 2.27 2.05 2.23
Total Equity 92 101 109.2 180.1 105.8 198.9 140.5 82.15 12.06
Non-Controlling Interest 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity 92 101 109.2 180.1 105.8 198.9 140.5 82.15 12.06
Retained Earnings -487.1 -457.5 -436 -340.5 -285.2 -165.9 -84.83 -41.56 -22.4
Accumulated Other Earnings 2.26 0.449 1.33 1.37 -0.526 0.05 0.007 -0.169 0.03
Common Stock 0.004 0.004 0.004 0.004 0.004 0.004 0.003 0.003 0.002
Preferred Stock 0 0 0 0 0 0 0 0 0
Additional Paid in Capital 576.9 558 543.9 519.2 391.6 364.7 225.4 123.9 34.43
Total Liabilities & Total Equity 119.9 127.9 141.5 212.8 132 216.4 151.9 92.13 17.26
Total Liabilities & Shareholders' Equity 119.9 127.9 141.5 212.8 132 216.4 151.9 92.13 17.26
Total Investments 0 0 0 0 0 0 0 0 0
Total Debt 0.82 1.42 1.77 3.63 3.98 2.23 0 0 0
Net Debt -66.41 -77.22 -104 -177.9 -110.7 -204.9 -147.8 -90.48 -16.88
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program